Purple Biotech Ltd (PPBT) ADR Each Representing 200 Ord Shares SPON

Sell:$2.96Buy:$3.29$0.08 (2.46%)

Prices delayed by at least 15 minutes
Sell:$2.96
Buy:$3.29
Change:$0.08 (2.46%)
Deal now
Prices delayed by at least 15 minutes
Sell:$2.96
Buy:$3.29
Change:$0.08 (2.46%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.

Key people

Eric K. Rowinsky
Chairman of the Board
Itzhak Israel
Chief Executive Officer & Director
Gil Efron
Deputy Chief Executive Officer, Chief Financial Officer
Gil Ben-Menachem
Vice President - Business Development
Avraham Ben-Tzvi
General Counsel, Secretary
Yisrael Gewirtz
Internal Auditor
Bertrand Liang
Chief Medical Officer
Hadas Reuveni
Founder and Chief Technology Officer of TyrNovo (a subsidiary)
Michael Schickler
Head of Clinical Operations
Robert E. Gagnon
Director
Suzana Nahum-Zilberberg
Director
Simcha Rock
Director
Ido Agmon
Independent Director
Steven Steinberg
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Israel
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US74638P2083
  • Market cap
    $9.44m
  • Employees
    20
  • Shares in issue
    529.64m
  • Exchange
    Tel Aviv Stock Exchange
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.